Provenienza dei contatti di primo grado di Pascalyne Wilson
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 16 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Pascalyne Wilson tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal | |
| MERCK KGAA | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ACHILLION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Human Resources Officer | |
| MERSANA THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| SOCIÉTÉ GÉNÉRALE | Regional Banks | Corporate Officer/Principal | |
| The Trustees of Columbia University in The City of New York | College/University | Corporate Officer/Principal | |
| BARCLAYS PLC | Investment Banks/Brokers | Director/Board Member | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Doctorate Degree | |
| MEDIGENE AG | Biotechnology | Director of Finance/CFO | |
3i Deutschland Gesellschaft für Industriebeteiligungen mbH
 3i Deutschland Gesellschaft für Industriebeteiligungen mbH Investment ManagersFinance 3i Deutschland Gesellschaft für Industriebeteiligungen mbH (3i Deutschland) is the German private equity subsidiary of 3i Group Plc (LSE: III) in Great Britain. Established in Frankfurt in 1984, the firm invests in small and medium-sized German companies at all stages of development, from start-ups to established businesses. In addition to the Frankfurt office, 3i Deutschland has offices in Munich and Stuttgart. They drive their investment focus and decisions from their Frankfurt and Munich offices, and the team collaborates with Swiss colleagues in Zurich and 3i's network across Europe, Asia and the U.S. to invest in a wide range of industry sectors. | Investment Managers | Private Equity Investor | |
The Grid
 The Grid Specialty TelecommunicationsCommunications Part of EarthLink LLC, The Grid is an internet service provider. The company is based in San Luis Obispo, CA. The Grid was acquired by Onemain.com, Inc., part of EarthLink LLC from September 12, 2000 on May 06, 1999 for $17 million. | Specialty Telecommunications | Director/Board Member | |
| University of Cambridge | College/University | Graduate Degree | |
| The University of Chicago | College/University | Doctorate Degree | |
| The Johns Hopkins University | College/University | Undergraduate Degree | |
| University of Toronto | College/University | Graduate Degree | |
Memorial Sloan Kettering Cancer Center
 Memorial Sloan Kettering Cancer Center Hospital/Nursing ManagementHealth Services Memorial Sloan-Kettering Cancer Center operates as a private cancer center. It offers cancer care services to adult; and child and teen patients. Its services include risk assessment and screening; diagnosis and treatment; clinical trials; patient and caregiver education; and pediatric clinical trials. The company was founded by John J. Astor and Charlotte Astor in 1884 and is headquartered in New York, NY. | Hospital/Nursing Management | Corporate Officer/Principal | |
The Juilliard School
 The Juilliard School Other Consumer ServicesConsumer Services The Juilliard School operates as an art school. It provides artistic education for musicians, dancers, and actors. The company was founded in 1905 and is headquartered in New York, NY. | College/University | Director/Board Member | |
| Ecole Polytechnique | College/University | Undergraduate Degree Undergraduate Degree | |
| École Normale Supérieure | College/University | Undergraduate Degree | |
Sanofi-Aventis U.S. LLC
 Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Takara Bio Europe AB
 Takara Bio Europe AB Miscellaneous Commercial ServicesCommercial Services Takara Bio Europe AB is a provider of stem cell derived products and technologies which will drive unprecedented innovation in drug discovery and regenerative medicine today and in the future. The company was first in the world to bring to the market human embryonic stem (hES) cell-derived hepatocytes and cardiomyocytes for use as drug discovery tools. Cellartis is also the single commercial source of ethically derived hES cell lines and has developed cell lines for a range of uses. This hES cell technology platform offers a path to tools and regenerative medicine discoveries of the future. The company was founded in 2001 and is headquartered in Gothenburg, Sweden. | Miscellaneous Commercial Services | Director/Board Member President General Counsel | |
| CARMAT | Medical Specialties | Chairman Director/Board Member | |
| PHARNEXT SCA | Biotechnology | Director/Board Member | |
Zodiac International SAS
 Zodiac International SAS Recreational ProductsConsumer Durables Zodiac International SASU provides boat building and repairing services. The company was founded in 1972 and is headquartered in Paris, France. | Recreational Products | Chairman | |
Boehringer Ingelheim France SASU
 Boehringer Ingelheim France SASU Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim France SAS engages in the research, development, marketing, and distribution of pharmaceuticals. The company was founded on October 31, 1986 and is headquartered in Paris, France. | Pharmaceuticals: Major | General Counsel | |
| Corps des Mines | Corporate Officer/Principal | ||
Nepteam SAS
 Nepteam SAS Financial ConglomeratesFinance Nepteam SAS provides financial services. The private company is based in Paris, France. and has subsidiaries in France. | Financial Conglomerates | Director/Board Member | |
| Downtown Community Television Center | Director/Board Member | ||
Medigene Immunotherapies GmbH
 Medigene Immunotherapies GmbH Pharmaceuticals: MajorHealth Technology Part of MediGene AG, Medigene Immunotherapies GmbH develops immunotherapy to treat cancer. The company is based in Planegg, Germany. The German company was founded in 2013 by Thomas Blankenstein, Dolores J. Schendel. The CEO is Axel-Sven Malkomes. Medigene Immunotherapies was acquired by MediGene AG on January 27, 2014 for $13.05 million. | Pharmaceuticals: Major | Chief Executive Officer | |
Voisin Consulting, Inc.
 Voisin Consulting, Inc. Miscellaneous Commercial ServicesCommercial Services Voisin Consulting, Inc. provides product development consulting services. It guides biotechnology, pharmaceutical and medical technology manufacturers throughout product development and commercialization. The company was founded by Emanuelle M. Viosin in 1997 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member | |
Cellectis, Inc.
 Cellectis, Inc. Pharmaceuticals: MajorHealth Technology Part of Cellectis SA, Cellectis, Inc. engages in the upstream research of genome engineering and in the development of pre-engineered products for pharmaceutical industry, cell therapies, seed companies, and laboratory researchers. The company is based in New York, NY. André Choulika has been the CEO of the company since 2014. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| Les Bastidons SA | Director/Board Member | ||
| Kotys SA | Director/Board Member | ||
| RELAY THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Hougou Finance SA
 Hougou Finance SA Financial ConglomeratesFinance Hougou Finance SA is an investment holding Belgian company founded in 2016. The private company is based in Ixelles, Belgium. | Financial Conglomerates | Director/Board Member | |
| Batuque Hotelaria E Turismo SA | Director/Board Member | ||
Babalia SA
 Babalia SA Financial ConglomeratesFinance Babalia SA provides investment services. | Financial Conglomerates | Chairman | |
Evok Hotels Collection
 Evok Hotels Collection Internet Software/ServicesTechnology Services Evok Hotels Collection provides a collection of information related to hotels and restaurants. | Internet Software/Services | Director/Board Member | |
| Louise 342-344 SA | Miscellaneous | Director/Board Member | |
Shango SA
 Shango SA Miscellaneous Commercial ServicesCommercial Services Shango SA is a Belgian company that provides business and management advisory services. The private company is based in Elsene, Belgium. The company was founded in 2013. | Miscellaneous Commercial Services | Director/Board Member | |
| Zaka | Director/Board Member | ||
Nepteam
 Nepteam Investment ManagersFinance Nepteam provides investment fund and financial services. | Investment Managers | Director/Board Member | |
Berlin Cures Holding AG
 Berlin Cures Holding AG BiotechnologyHealth Technology Part of Berlin Cures GmbH, Cures Holding AG is a Swiss joint stock company based in Zug, Switzerland. Cures Holding AG specializes in developing a neutralizer for pathogenic functional autoantibodies. The company is home to an unrivaled platform-technology established around BC 007. The company was founded in 2014 by Johannes Müller, and Oliver von Stein has been the CEO of the company since 2023. | Biotechnology | Chairman | |
| Universite Louis Pasteur Strasbourg I | College/University | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 19 |
| Francia | 18 |
| Germania | 5 |
| Regno Unito | 3 |
| Lussemburgo | 3 |
Settori
| Health Technology | 17 |
| Consumer Services | 11 |
| Finance | 8 |
| Commercial Services | 5 |
| Producer Manufacturing | 2 |
Posizioni
| Director/Board Member | 79 |
| Corporate Officer/Principal | 25 |
| Chairman | 23 |
| Independent Dir/Board Member | 16 |
| Chief Executive Officer | 11 |
Contatti più connessi
| Insiders | |
|---|---|
| Pierre Bastid | 29 |
| Jean-Pierre Garnier | 28 |
| Laurent Arthaud | 21 |
| David Sourdive | 16 |
| Rainer Boehm | 12 |
| Donald Bergstrom | 9 |
| André Choulika | 8 |
| Axel-Sven Malkomes | 7 |
| Stephan Reynier | 6 |
| Marie-Bleuenn Terrier | 6 |
| Kyung Nam-Wortman | 5 |
| Mark Frattini | 5 |
| Arthur Stril | 4 |
| Steve Doares | 3 |
| Cécile Chartier | 3 |
- Borsa valori
- Insiders
- Pascalyne Wilson
- Connessioni Società
